コロナウイルス感染症2019（COVID-19）：臨床・市販用分析装置（2022年8月）

COVID-19の発生が常に進化しているため、企業は新興ワクチンと治療薬法の成功の可能性について迅速に更新された詳細な情報を必要としています。

当レポートはパイプライン段階の主要なワクチンおよび治療薬を、入手可能な臨床データに基づいてさまざまな臨床・商業パラメータで採点する、対話型のエクセルベースのツールです。競合情勢、製品ダッシュボード、各製品の独自のSWOT分析、臨床データ概要など、包括的な情報を提供しています。また安全性や有効性などの臨床的特徴、価格や企業の評判、マーケティング能力などの商業的特徴をスコアリングで表示します。この更新版には、オミクロン・バリアントが製品に与える影響についての加重表示が含まれています。

目次

第1章 目次

• カタリスト
• 範囲と調査手法
• 臨床・市販用分析装置：治療薬法
• 競合力評価：治療薬法
• 製品のダッシュボード：治療薬法
• 臨床データ：治療薬法
• 臨床・市販用分析装置：ワクチン
• 競合力評価：ワクチン
• 製品のダッシュボード：ワクチン
• 臨床データ：ワクチン
• GlobalDataについて

The Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer looks at the data from clinical trials for vaccines and therapeutics either currently marketed or in the pipeline. The data is assessed, and the different products are compared against each other both clinically and commercially.

This report is an update of the previous COVID-19 Clinical and Commercial analyzer, which analyzes the available data of pipeline and marketed therapeutics and vaccines for COVID-19.

Report deliverables are an interactive Excel-based that has the Analyzer tab, which weights different clinical and commercial contributors per product, the competitive assessment tab, which is a graph representing the products by their clinical and commercial scores, the dashboard tab, which gives details and a SWOT analysis of each product, and the clinical data tab, which lists the key clinical trials and data for the products.

This update includes a weighted view of the impact of the Omicron variant on the products

Scope

• In depths assessment of the marketed and pipeline products for COVID-19, analyzing the clinical and commercial aspects of the products against one another.
• This update includes a weighted view of the impact of the Omicron variant on the products

Reasons to Buy

• Develop and design your in-licensing and out-licensing strategies through a review of marketed and pipeline products and technologies, and by identifying the companies with the most robust pipeline and marketed products.
• Understand the strengths and weaknesses of pipeline and marketed products, and how they compare against one another.
• Develop business strategies by understanding the trends shaping and driving the COVID-19 market.
• Drive revenues by understanding the key trends, innovative products and technologies, and companies likely to impact the global COVID-19 vaccine and therapeutic market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Table of Contents

1. Table of Contents

• 1.1 Catalyst
• 1.2 Scope & Methodology
• 1.3 Clinical and Commercial Analyzer: Therapeutics
• 1.4 Competitive Assessment: Therapeutics
• 1.5 Product Dashboard: Therapeutics
• 1.6 Clinical Data: Therapeutics
• 1.7 Clinical and Commercial Analyzer: Vaccines
• 1.8 Competitive Assessment: Vaccines
• 1.9 Product Dashboard: Vaccines
• 1.10 Clinical Data: Vaccines
• 1.11 About GlobalData